Wes Edens is one of the most successful investors in the United States and brings his unique style to investing in various fields. In 2017, he acquired Fortress Biotech at an initial public offering worth $300 million, which was on track to be the largest IPO in Colorado history. Edens’s total assets are estimated to be valued at 1.8 billion dollars, and in the past year, he has made his biggest splash by becoming a co-owner of the Milwaukee Bucks, one of the most successful NBA teams.

Wes Edens grew up in Oregon and attended Oregon State University, where he earned a Bachelor’s degree in Finance and Business Administration. After he graduated from college, Wes Edens found his first job as an investment banker with Lehman Brothers. He spent six years with the company before leaving to pursue his path in the financial and investment services industry.

Edens launched the New Mountain Finance Company, which worked exclusively in the private equity market. The company benefited from Edens’ vast knowledge of finance and business, which he acquired from working for Lehman Brothers. After only five years, Wes Edens made significant acquisitions to grow and expand his company. He purchased Industrial Specialties Group, Inc. for $1.5 billion, a turn of events that would eventually lead to the company being traded on the New York Stock Exchange. In 2009, WSJ named Edens and his business partner as two of the best-performing CEOs in New York for that year.

In 2010, Wes Edens took his successes a step further by taking a controlling interest in Fortress Paper Corp., founded by William Ackman. As a co-founder of Fortress Investment Group, Wes Edens has helped the company become one of the largest private equity firms working in near-prime and sub-prime lending.

Wes Edens is one of the most accomplished investors in the United States, and his early career was spent working on Wall Street to help fund his latest endeavors. He gained the knowledge that brought him to where he is today through years of experience with investment banking and private equity firms. Refer to this page for additional information.